Obexa Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
- Satisfied Charges ₹ 7.50 M
- Revenue Growth 13.24%
- Profit Growth -77.42%
- Ebitda -133.75%
- Net Worth 7.98%
- Total Assets 58.61%
About Obexa Pharmacare
Obexa Pharmacare Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2017 (Eight years 1 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shivam Bansal, Poonam Bansal, and Manav Bansal serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909CH2017PTC041368
-
Company No.
041368
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Obexa Pharmacare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivam Bansal
|
Director | 06-Feb-2017 | Current |
|
Poonam Bansal
|
Director | 06-Feb-2017 | Current |
|
Manav Bansal
|
Director | 30-Jul-2020 | Current |
Financial Performance of Obexa Pharmacare.
Obexa Pharmacare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.24% increase. The company also saw a substantial fall in profitability, with a 77.42% decrease in profit. The company's net worth moved up by a moderate rise of 7.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Obexa Pharmacare?
Unlock access to Obexa Pharmacare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.00 M
₹7.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2024 | Hdfc Bank Limited | ₹9.00 M | Open |
| 24 Nov 2020 | Others | ₹6.50 M | Satisfied |
| 15 Jan 2020 | Others | ₹1.00 M | Satisfied |
How Many Employees Work at Obexa Pharmacare?
Unlock and access historical data on people associated with Obexa Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Obexa Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Obexa Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.